معرفی
Piyush Padhi is a Researcher affiliated with the College of Veterinary Medicine at the University of Georgia. His work focuses on developing genetically engineered microbial technologies to tackle neurodegenerative diseases like Parkinson's and Alzheimer's. He investigates the interplay between gut microbiota, mitochondrial dysfunction, and neuroinflammation in chronic neurological disorders. His research integrates CRISPR-Cas9 gene editing, microencapsulation, and novel drug delivery systems to create targeted therapies.
Key areas of exploration include the etiopathogenesis of neurodegenerative diseases through environmental chemical impacts, dopaminergic neuronal protection using mito-metformin, and leveraging humanized mouse models (e.g., Tau-FAD mice) to study disease mechanisms. His interdisciplinary approach bridges synthetic biology, neuropharmacology, and environmental health, with recent publications addressing C. difficile infection's effects on brain dopamine metabolism and the gut-brain axis's role in autism spectrum disorders.
Research outputs emphasize translational applications such as microbially produced levodopa for Parkinson's treatment and aggregation-inhibiting therapies for α-synucleinopathies. His studies also explore organic dust-induced neuroinflammation and mitochondrial protective agents like mito-apocynin. Collaborative efforts involve veterinary diagnostic laboratories and pharmaceutical development, though specific grant details or lab affiliations are not explicitly detailed in the provided texts.
